A Phase 1, Single-Dose, Open-Label, Two-Period, Randomised, Crossover Study Assessing the Effect of Food (Fasted or Fed State) on Pharmacokinetics of Fenfluramine (ZX008) Oral Solution in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2018
Price : $35 *
At a glance
- Drugs Fenfluramine (Primary)
- Indications Dravet syndrome; Epilepsy; Lennox-Gastaut syndrome
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Zogenix
- 22 Jun 2018 Results published in the Clinical Therapeutics Journal.
- 03 Jan 2018 New trial record
- 05 Dec 2017 Results presented at the 71st Annual Meeting of the American Epilepsy Society.